Stock Novartis AG NVS

Investlytic score: 3/5 criteria met.

• ✅ Price trend passed
• ✅ Growth passed
• ❌ Debt failed
• ✅ P/E passed
• ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2018 → 2019: 24.81%

Price change 2019 → 2020: -0.27%

Price change 2020 → 2021: -7.37%

Price change 2021 → 2022: 3.72%

Price change 2022 → 2023: 17.61%

Price change 2023 → 2024: -3.62%

Price change 2024 → 2025: 41.68%

Price change 2025 → 2026: 13.26%

Price change 2026 (year to date): 12.71%

Financial growth

Revenue CAGR (8 years): 2.50%

Earnings CAGR (8 years): 1.56%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 0.80

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 16.23

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 7.40% from the high over 6 months.

Insufficient correction (< 10.0%).